Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Liquid Maltitol stands out as a sugar alcohol used for its sweetening power and low caloric impact, making it a critical ingredient across pharmaceutical, food, and nutraceutical sectors. As a clear, colorless to slightly yellow viscous liquid, this compound offers a sweet taste that stacks faintly below sucrose, yet it delivers sweetness without compromising goals around calorie reduction. Chemically, Liquid Maltitol carries the formula C12H24O11 and comes with a molar mass of 344.31 g/mol. What makes this grade different lies in its strict adherence to the standards set forth by BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia), assuring deliverability for regulated applications. An HS code, which classifies it for international trade and customs, typically lists under 29054900 for sugar alcohols. Understanding a compound like maltitol at this technical level helps avoid confusion when selecting excipients that affect medication or supplement performance, especially when patient safety and product reliability matter.
Not just a generic filler, Liquid Maltitol’s properties are dialed in for specialized applications. As a polyol, its structure contains multiple hydroxyl groups, which reduce glycemic impact while resisting fermentation by oral bacteria. With a density hovering near 1.32 g/cm3 at 20°C, Liquid Maltitol pours thicker than water and holds consistent viscosity over time, giving formulators a reliable outcome during processing. Solubility ranks high, outpacing many alternatives—dissolving quickly in water and staying miscible without clouding or separating. Thermal stability sits firmly in the moderate range, holding up well during both low- and mid-range heating, though consistent exposure to temperatures over 150°C can start to degrade integrity. The chemical property profile aligns Maltitol for use in syrups, suspensions, or oral disintegrating tablets, which require not just structural support but also transparency and pleasant taste. The non-crystallizing nature of the liquid variant ensures even distribution in solution, preventing settling or grittiness, especially in high-concentration formulas.
Liquid Maltitol BP EP USP Pharma Grade ships in a variety of concentrations, but most standards place total polyols at 50-80% by weight. The product often arrives in bulk containers or drums, requiring clean, dry storage to maintain specification. Specific purity requirements keep heavy metal content extremely low (often <5 ppm), with residual solvents nearly undetectable. Each batch provides microbiological purity and an absence of hazardous impurities—criteria mandated under BP, EP, and USP standards. While available as powder, flakes, solid, pearls, and even crystalline variants, the liquid form dominates in pharmaceutical manufacturing thanks to its fast integration and high homogeneity with water and other excipients. Buyers should always request and review the COA (certificate of analysis), SDS (safety data sheet), and full batch testing records to align with regulatory needs for traceability and patient safety. Bulk density can fluctuate slightly around 1.28-1.33 g/cm3, and viscosity can swing from 10,000 to 20,000 mPa.s, so temperature-controlled environments protect integrity in storage and transit.
Safety remains a prime concern in pharmaceutical ingredient selection. Liquid Maltitol carries a GRAS (Generally Recognized As Safe) status by the U.S. FDA at typical usage levels. Acute toxicity sits very low, with no mutagenic, carcinogenic, or teratogenic effects documented in regulatory reviews or peer-reviewed studies. Users rarely report allergic effects, and it serves as a viable alternative for those with allergies to common sugars or who manage diabetes—though high doses may lead to gastrointestinal discomfort. Maltitol’s safety margin extends from its chemical stability and inertness, reducing risk when blended with active pharmaceutical ingredients. The raw material process typically begins from cereal starch (often corn or wheat), hydrolyzed and then hydrogenated to yield the finished polyol. Hazard classification remains minimal—non-flammable, non-explosive, and not labeled as harmful for transportation or regular manufacturing. Responsible manufacturing and thorough material screening block the introduction of harmful contaminants and minimize the risk of cross-contamination with allergens, pesticides, or heavy metals.
Liquid Maltitol BP EP USP Pharma Grade fills a pivotal role as a raw material and excipient in tablet syrups, lozenges, chewable supplements, and other patient-facing drug forms where taste and texture can make or break therapy compliance. Its chemical profile means manufacturers can cut reliance on sucrose, supporting therapies for diabetic or calorie-controlled diets. Maltitol’s stable viscosity and clarity help formulators build transparent syrups that carry flavor and colorings without clouding, matching consumer expectations and regulatory requirements for both over-the-counter and prescription therapies. I have worked with medication and supplement projects where alternatives either crystallized on the shelf or altered the taste so much they lost sales. Liquid Maltitol’s consistency allows high-volume, repeatable processing. Its role goes beyond pharma; it improves mouthfeel and functional properties in products from sugar-free chocolate to gum, lowering glycemic spikes while maintaining palatability. In each case, the traceability, safety, and dependability of pharma-grade liquid maltitol give manufacturers and consumers confidence in the final product’s quality and safety.
Global pharmaceutical, food, and nutraceutical industries demand unwavering reliability and transparency in their excipient supply, especially when patient health depends on consistent composition. Full documentation, including transparency around HS Code classification, purity, molecular formula, density, and solubility, supports customs clearance and quality assurance processes worldwide. Continuous monitoring for elemental impurities, batch-to-batch consistency, and allergen risk forms part of every shipment’s quality dossier. Industry-leading manufacturers rely on analytical testing—chromatography, spectrometry, and microbiological assays—to confirm compliance for every batch, supporting traceability efforts dating back from finished medicine to initial raw material. This process not only supports regulatory submissions but offers patients tangible benefits: safety, efficacy, and the assurance that every bottle or pill contains exactly what the label promises, with no hidden risks and no cutting of corners in the supply chain. Quality reporting and adherence to accepted international standards cannot substitute for robust supplier vetting and ongoing due diligence—those in charge of sourcing and compliance see first-hand how critical it is to trust, but also verify, every lot that enters the production line.
Chengguan District, Lanzhou, Gansu, China
